MFDS (KFDA) approval of Anyfusion blood transfusion pump (BTP) and Development of CAM | |
---|---|
Anyfusion Blood Transfusion Pump (BTP) has
been certified by the Ministry of Food and Drug Safety (MFDS) through clinical
trials for hemolysis in the range of 300cc per hour, which can be transfused
without a warmer at Wonju Severance. We built Anyfusion platform products
portfolio with the completion of the development and approval of the drug
injection pump, PCA, ACPi, and BTP, which are the Anyfusion platform products. All of the leading global Anyfusion
Platform Products are developing smart ICT (HIS-linked) IoT systems with the
goal of completion by 2021. We are now ready to put an end to the EZ
Regular single item business. We started sales through domestic and overseas
sales departments. Anyfusion H100 is a PCA for self-pain
control of cancer patients, and demo is in progress at the best major hospitals
in Korea. We decided to re-develop the CAM (Closed System Assembly Machine)
that automatically connects the anticancer drug and the CSTD developed by the
company to the manual ACPi V100 into a design (form) that meets the needs of
the customer. If the demo was unreasonable to achieve
early sales with the already developed CAM rather than the consumer, On the
contrary, rather than losing credibility, it was judged that it was important
to develop a CAM that meets ACPi innovation by minimizing the safety and risk
of the consumer (pharmacist) and improving the convenience. That's why we redeveloped. Due to Corona 19, the introduction of
anticancer drug preparation robots was not smooth, and installation of robots
was delayed in many hospitals, and based on consumer-centered reliability, it
is believed that a proper product considering the domestic and overseas markets
with manual ACPi will be rather an opportunity. There seems to be a delay of
about 1 month. In February-April 2021, when the government
support task is announced, in order to enter global markets such as the United
States, Japan, and Germany by building completeness and high clinical
reliability of ACPi, PCA, BTP products, we are negotiating to carry out support
projects for global clinical tests (K univ.), usability tests (Y units),
verification verification (A univ.), ICT, IoT Smart System construction (S univ.),
etc. We will meet the expectations of those who
give support and support to the manual ACPi V100 and the leading HIS connection
semi-automatic ACPi Pro, and the automatic AACPi Pro and HIS connection IoT
system Anyfusion H100. With the inauguration of the US President
Biden, a direct humanitarian deal with Iran was established, and we are
discussing about 1 billion won in EZ Regular sales and ACPi entry into Iran. Thank you. |
Next | Technology evaluation results of the injection preparation kit and System |
---|---|
Prev | Approval(KFDA) for manual anticancer drug preparation ACPi Anyfusion V100 |